In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption
| Image |  |
|---|---|
| Description | scientific article published in February 2012 |
| Author/s |
author: Thierry Chardès Caroline Bascoul-Mollevi David Azria |
| Publication date | February 1, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |